pregna-1,4-diene-11-ol-3,20-dione: RN given refers to 11beta-isomer in Chemline; RN for unspecified isomer not in Chemline 7/11/83 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3080605 |
| SCHEMBL ID | 11044326 |
| MeSH ID | M0115618 |
| Synonym |
|---|
| pregna-1,4-diene-11-ol-3,20-dione |
| pregna-1,4-diene-3,20-dione, 11-hydroxy-, (11beta)- |
| delta-hop |
| (8s,9s,10r,11s,13s,14s,17s)-17-acetyl-11-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one |
| 4224-37-7 |
| SCHEMBL11044326 |
| DTXSID40962390 |
| 11-hydroxypregna-1,4-diene-3,20-dione |
| Excerpt | Relevance | Reference |
|---|---|---|
| " In contrast, glucocorticoids produced the classical dose-response inhibition and the effect persisted when they were removed from the cultured medium." | ( Inhibitory effect of 11 beta-hydroxypregna-1,4-diene-3,20-dione (delta HOP) on lymphocyte proliferation. Castillo, MB; Roldán, A; Rondinone, CM; Schillaci, R, 1991) | 0.28 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.46) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||